Cargando…

Development of a bedside tool to predict the probability of drug-resistant pathogens among hospitalized adult patients with gram-negative infections

BACKGROUND: We developed a clinical bedside tool to simultaneously estimate the probabilities of third-generation cephalosporin-resistant Enterobacteriaceae (3GC-R), carbapenem-resistant Enterobacteriaceae (CRE), and multidrug-resistant Pseudomonas aeruginosa (MDRP) among hospitalized adult patients...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lodise, Thomas P., Bonine, Nicole Gidaya, Ye, Jiatao Michael, Folse, Henry J., Gillard, Patrick
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2019
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6694572/ https://www.ncbi.nlm.nih.gov/pubmed/31412809 http://dx.doi.org/10.1186/s12879-019-4363-y

Ejemplares similares

1166. Development of a Bedside Tool to Predict the Probability of Drug-Resistant Pathogens Among an Adult Population With Gram-Negative Infections
por: Lodise Jr., Thomas P, et al.
Publicado: (2018)

Associations Between Timeliness of Therapy and Clinical and Economic Outcomes Among Patients With Serious Infections Due to Gram-negative Bacteria (GNB): How Much Does Delayed Appropriate Therapy (DAT) Matter?
por: Bonine, Nicole G, et al.
Publicado: (2017)

Contemporary treatment utilization among women diagnosed with symptomatic uterine fibroids in the United States
por: Bonine, Nicole Gidaya, et al.
Publicado: (2020)

Carbapenem-resistant Enterobacteriaceae (CRE) or Delayed Appropriate Therapy (DAT)—Does One Affect Outcomes More Than the Other Among Patients With Serious Infections Due to Enterobacteriaceae?
por: Lodise, Thomas, et al.
Publicado: (2017)

Antimicrobial Resistance or Delayed Appropriate Therapy—Does One Influence Outcomes More Than the Other Among Patients With Serious Infections Due to Carbapenem-Resistant Versus Carbapenem-Susceptible Enterobacteriaceae?
por: Lodise, Thomas P, et al.
Publicado: (2019)

1485. Trends in Important-Resistant Gram-Negative (GN) and Gram-Positive (GP) Urine Bacterial Pathogens in Hospitalized Patients in the United States: A Multicenter Evaluation from 2013 to 2018
por: Lodise, Thomas, et al.
Publicado: (2019)

1191. Prevalence and Microbiology of Carbapenem Resistance Among Six Gram-Negative Pathogens in Bloodstream Infections in US Hospitals, 2010–2015
por: Lodise, Thomas P, et al.
Publicado: (2018)

1041 Economic Burden Associated with Key Gram-negative Pathogens among Patients with Complicated Urinary Tract Infections across US Hospitals
por: Mocarski, Michelle, et al.
Publicado: (2014)

Effect of prior receipt of antibiotics on the pathogen distribution and antibiotic resistance profile of key Gram-negative pathogens among patients with hospital-onset urinary tract infections
por: Bidell, Monique R., et al.
Publicado: (2017)

Does Timing of Receipt of Appropriate Antimicrobial Therapy Make a Difference Among Patients With Serious Infections Due to Resistant Gram-Negative Pathogens?
por: Berger, Ariel, et al.
Publicado: (2016)

Direct Costs Incurred Among Women Undergoing Surgical Procedures to Treat Uterine Fibroids
por: Harrington, Amanda, et al.
Publicado: (2020)

Bench-to-bedside review: The role of β-lactamases in antibiotic-resistant Gram-negative infections
por: Bush, Karen
Publicado: (2010)

Frequency of Extensively Drug-Resistant Gram-Negative Pathogens in a Tertiary Care Hospital in Pakistan
por: Abbas, Sundas, et al.
Publicado: (2020)

Pixantrone Sensitizes Gram-Negative Pathogens to Rifampin
por: She, Pengfei, et al.
Publicado: (2022)

Novel Antimicrobial Agents for Gram-Negative Pathogens
por: Karvouniaris, Marios, et al.
Publicado: (2023)

Bactericidal Effect of Cecropin A Fused Endolysin on Drug-Resistant Gram-Negative Pathogens
por: Lim, Jeonghyun, et al.
Publicado: (2022)

216. Association Between Days to Initiate Appropriate Therapy and Hospital Length of Stay Among Adult Hospitalized Patients With Gram-negative Bloodstream Infections (GN-BSI)
por: Lodise, Thomas, et al.
Publicado: (2019)

Prognostic factors and monomicrobial necrotizing fasciitis: gram-positive versus gram-negative pathogens
por: Lee, Ching-Yu, et al.
Publicado: (2011)

Current Epidemiology and Growing Resistance of Gram-Negative Pathogens
por: Livermore, David M.
Publicado: (2012)

Heme Uptake and Utilization by Gram-Negative Bacterial Pathogens
por: Richard, Kaylie L., et al.
Publicado: (2019)

Thymine Sensitizes Gram-Negative Pathogens to Antibiotic Killing
por: Liu, Yuan, et al.
Publicado: (2021)

Secretion Systems in Gram-Negative Bacterial Fish Pathogens
por: Mekasha, Sophanit, et al.
Publicado: (2021)

CRISPR-Cas System: A Tool to Eliminate Drug-Resistant Gram-Negative Bacteria
por: Kundar, Rajeshwari, et al.
Publicado: (2022)

Multidrug-resistant and extensively drug-resistant Gram-negative pathogens: current and emerging therapeutic approaches
por: Karaiskos, Ilias, et al.
Publicado: (2014)

In Vitro Activity of Cefiderocol against Multi-Drug Resistant Carbapenemase-Producing Gram-Negative Pathogens
por: Boyd, Sandra, et al.
Publicado: (2017)

Novel Fluoroquinolones with Possible Antibacterial Activity in Gram-Negative Resistant Pathogens: In Silico Drug Discovery
por: Coba-Males, Manuel Alejandro, et al.
Publicado: (2023)

Mechanisms of Antibiotic Resistance in Important Gram-Positive and Gram-Negative Pathogens and Novel Antibiotic Solutions
por: Kakoullis, Loukas, et al.
Publicado: (2021)

Non-Aqueous Glycerol Monolaurate Gel Exhibits Antibacterial and Anti-Biofilm Activity against Gram-Positive and Gram-Negative Pathogens
por: Mueller, Elizabeth A., et al.
Publicado: (2015)

Phosphoethanolamine Transferases as Drug Discovery Targets for Therapeutic Treatment of Multi-Drug Resistant Pathogenic Gram-Negative Bacteria
por: Thai, Van C., et al.
Publicado: (2023)

Activity of siderophores against drug-resistant Gram-positive and Gram-negative bacteria
por: Gokarn, Karuna, et al.
Publicado: (2018)

Antimicrobial Activity of Ibuprofen against Cystic Fibrosis-Associated Gram-Negative Pathogens
por: Shah, Parth N., et al.
Publicado: (2018)

New Disturbing Trend in Antimicrobial Resistance of Gram-Negative Pathogens
por: Lee, Jung Hun, et al.
Publicado: (2009)

Therapy of Infections due to Carbapenem-Resistant Gram-Negative Pathogens
por: Lee, Chang-Seop, et al.
Publicado: (2014)

Role and regulation of heme iron acquisition in gram-negative pathogens
por: Runyen-Janecky, Laura J.
Publicado: (2013)

QseC Inhibitors as an Antivirulence Approach for Gram-Negative Pathogens
por: Curtis, Meredith M., et al.
Publicado: (2014)

Antibiotic consumption and resistance of gram-negative pathogens (collateral damage)
por: Cižman, Milan, et al.
Publicado: (2018)

Fosfomycin in infections caused by multidrug-resistant Gram-negative pathogens
por: Ruiz Ramos, Jesús, et al.
Publicado: (2019)

A new antibiotic selectively kills Gram-negative pathogens
por: Imai, Yu, et al.
Publicado: (2019)

Bicyclomycin Activity against Multidrug-Resistant Gram-Negative Pathogens
por: Wang, Weijie, et al.
Publicado: (2022)

Baicalein Resensitizes Multidrug-Resistant Gram-Negative Pathogens to Doxycycline
por: Wang, Yuhang, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_fmdti966arfgnur95tmnv13rqj